1. PC.01.6 A MULTIDISCIPLINARY APPROACH TO FAMILIAL PANCREATIC CANCER ENRICHES THE PROPORTION OF PATIENTS WITH GENETICALLY CONFIRMED PANCREATIC CANCER SUSCEPTIBILITY. Issue 2 (15th March 2018) Authors: Cavestro, G.M.; Mannucci, A.; Zuppardo, R.A.; Crippa, S.; Reni, M.; Zanon, S.; Zambetti, M.; Patricelli, M.G.; Raucci, A. Russo; De Cobelli, F.; Arcidiacono, P.G.; Gianni, L.; Testoni, P.A.; Falconi, M. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program. (April 2018) Authors: Pivot, X.; Poole, C.; Martín, M.; Gligorov, J.; Barrios, C.H.; Vrdoljak, E.; Zambetti, M.; Woodward, N.; Ten Tije, A.J.; Lindegger, N.; Crespel, G.; Truman, M.; Steger, G.G. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗